Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

Posterior chamber phakic implantable collamer lens outcomes with at least 1 year of follow-up

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Phakic IOLs III

Session Date/Time: Tuesday 13/09/2016 | 09:30-11:00

Paper Time: 09:30

Venue: Poster Village: Pod 4

First Author: : P.Schraepen BELGIUM

Co Author(s): :    E. Mertens              

Abstract Details


The purpose of this study was to assess the visual and refractive outcomes of the ICL V4C model for myopia and myopic astigmatism correction after at least 1 year follow-up.


Medipolis, Antwerp Private Clinic, Belgium


245 eyes of 152 patients underwent implantation of myopic or toric implantable collamer lens (V4C model, STAAR Surgical Inc) for myopia or myopic astigmatism correction. All surgeries in this study were performed by one experienced surgeons (E.M.) using topical and intracameral anesthesia. Mean spherical refraction was -5.06±3.64 diopters (D) (range: -18.25 to -0.75 D), and mean cylinder was –1.10±1.19 D (range: -8.00 to -0.75 D). Main outcomes measures evaluated during a year follow-up included: uncorrected visual acuity (UCVA), refraction, best corrected visual acuity (BCVA), vault, intraocular pressure (IOP).


During the surgical procedures, there were no complications. After 1 year the mean Snellen decimal UCVA was 1.13±0.10 and mean BCVA was 1.11±0.09. The mean spherical equivalent dropped from -5.65±3.59 D to -0.01±0.09 D (ranging from -0.25 to 1.00 D). No adverse events were found during the follow-up period (vault and IOP values were maintained stable during the postoperative period). No eye needed explantation and decentration of the ICL optic was not observed, and no case of pupillary block was detected.


The results of the present study reveal the good outcomes of the new implantable collamer lens V4C model for hyperopic, myopic and myopic astigmatism correction.

Financial Disclosure:

One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to previous